Don Leonardi Gutierrez de la Huerta ... Tractatus de Compensationibus ... : tomus primus.

Texto a dos col., anteportada.

Tractatus et synopsis totius iuris feudalis : conclusionibus et sententiis in capita duodecim familiari methodo digestus ... : adiectis singularum conclusionum argumentis et sumarijs ... : ab ipsomet auctore mirum in modum auctus locupletatus /

Mode of access: Internet.

Aurei compendii decisionum regalium supremorum tribunalium fidelissimi Regni Neapolitani, nempe regii collateralis consilii, sacri regij consilij S. Clarae ... Ex recentioribus auctoribus recollectarum ... Pars secunda /

Mode of access: Internet.

Didaci Couarruuias a Leyua toletani Episcopi Segobiensis ... Omnia opera : multò quàm priùs emendatiora, ac multis in locis auctiora in duos diuisa tomos ... : tomus primus.

Index seu Repertorium materiarum ac vtriusque Iuris decisionum, quae in hoc secundo [sic] tomo continentur ... concinnatum per Alfonsum Gonçalez à Turre ..., con port. propia (con fecha 1583), [99] p.;en el recto de h. a2 consta "... quae in hoc priori tomo ..."

Psychagogia, hoc est, animae recreatio quatuor libris distincta : quorum tres priores collecti sunt ex tractatibus sive homilijs Diui Aurelij Augustini Hipponensis Episcopi : quartus decerptus est ex scriptis B. Gregorii Papæ /

BM STC Italian, 1465-1600,

Historia de Venezuela, escrita en 1581

Mode of access: Internet.

Vite de' pittori, scultori ed architetti napoletani /

Reprint. Originally published: Napoli: Ricciardo, 1742-1743.

ORLANDO COSTAS: ENSAIOS NO CAMINHO PARA UMA PASTORAL EVANGÉLICA LATINO-AMERICANA

Nesta pesquisa se propõe analisar a pastoral evangélica latino-americana elaborada por Orlando Costas. Teólogo pastoralista, missiólogo e de origem porto-riquenha, Costas elaborou método e metodologia de pastoral a partir de sua confissão religiosa evangelical em diálogo ecumênico e em consonância crítica com a situação política, econômica, social e religiosa de Porto Rico e da América Latina. Costas, juntamente com Emilio Castro, foi um dos primeiros a lançar as bases para uma pastoral evangélica visando ao homem latino-americano. Criticou o modelo da teologia pastoral norte-atlântica centrada no pastor com sujeito da ação pastoral da igreja alegando ser; repetitiva, profissional e eclesiocêntrica. A pesquisa foi realizada em três passos, que se realizam nos capítulos um, dois e três, respectivamente, compreender o contexto político, econômico, social e religioso da vida de Orlando Costas a partir de Porto Rico, suas experiências de conversão-ruptura dentro da sua tradição religiosa e a nova percepção pastoral; analisar o desenvolvimento histórico teológico da pastoral evangélica, ou seja, os movimentos, conferências, instituições e teólogos que influenciaram o pensamento de Costas; e, apresentar os fundamentos missiológicos e teológicos da pastoral evangélica, em que se demonstra que a pastoral de Costas é missiológico-pastoral, pois assume a missio Dei como princípio arquitetônico e a pastoral como princípio hermenêutico para a ação missional e pastoral. Conclui-se que a proposta de Costas é de uma pastoral evangélica e ecumênica, contextual e autóctone, dentro e fora da igreja.(AU)

The PTA: Promoting Swiss Tours, 1888-1939

This research examines the development from educational to commercial tourism in Britain between the late-nineteenth and early-twentieth century by questioning whether this reflected a transformed understanding of the role of travel within society. It focuses on the Polytechnic Touring Association (PTA), a London-based originally philanthropic travel organisation that became a commercial firm. During this period the PTA moved from the project of contributing to the education of citizens to the market-led imperative of ‘harnessing’ a consumer desire. In examining this transformation via the PTA’s changing approach to the visual promotion of its Swiss tours, we suggest that the development of the tourism industry in Britain should also be explored in relation to changing ideas about travel’s contribution to social formation.

Petrus Hispanus O.P. Auctor Summularum (III) ¿”Petrus Alfonsi” o “Petrus Ferrandi”?

Este artículo pretende ser complemento y continuación de mis anteriores trabajos sobre la figura de Petrus Hispanus O. P., Auctor Summularum. Comienzo presentando algunos nuevos documentos relacionados con las cuestiones ya examinadas en mis artículos de 1997 y 2001. A continuación, me ocupo de las cuestiones aplazadas en el artículo de 2001: los problemas relativos a la figura de “Petrus Ferrandi” y su posible relación con el “auctor Summularum”, así como los argumentos de Tugwell contra la hipótesis de la posible identidad de estas dos figuras, examinados ahora desde la perspectiva del autor de la Legenda prima. Tras analizar testimonios procedentes de muy diversos ámbitos, afirmo, por una parte, que la hipótesis de la identidad entre “Petrus Ferrandi” y “Petrus Hispanus” podría ser correcta y, por otra parte, que no hay argumentos concluyentes que obliguen a afirmar con seguridad que el autor de la Legenda prima es Pedro Ferrando. Aunque los análisis no permiten por el momento determinar si es “Petrus Alfonsi” o “Petrus Ferrandi” el “auctor Summularum”, los testimonios recogidos y las conexiones establecidas contribuirán, sin duda, a orientar futuras investigaciones en torno a la figura de “Petrus Hispanus”.

Effects of simvastatin in abdominal sepsis in rats

Statins are widely recognized as hypolipemic drugs, but some studies have observed anti-inflammatory and immunomodulatory effects, known as pleiotropic. The aims of this work was to study possible anti-inflammatory effects of simvastatin in abdominal sepsis. Serum pro-inflammatory cytokines and leukocytes count were determined in an experimental model of abdominal sepsis, using cecal ligation and puncture (CLP) in rats. Methods: Twenty eigth Wistar rats weighing 285±12g were randomly divided in: CLP/Sinvastatin rats (n=7), treated with 10 mg/Kg of oral simvastatin 18 and 2 hs berofe CLP; CLP/Saline group rats (n=7), treated with oral saline; group Sham/Simvastatin (n=7), treated with simvastatin, and group Sham/Saline (n=7), treated with saline. Serum TNF-α, IL-1β and IL-6 by ELISA and total leukocytes, neutrophils, lymphocytes, and eosinophils were determined 24 hs after CLP. ANOVA and Tukey test were used considering significant p<0.05. Results: It was demonstrated that serum TNF-α, IL-1β and IL-6 were respectively 364,8±42pg/mL; 46,3±18pg/mL and 28,4±13pg/mL in CLP/Sinvastatin rats, significantly lower (p<0.05) than in group CLP/Saline (778,5±86pg/ml; 176,9±46pg/ ml; 133,6±21 pg/ml, respectively). The same results were observed in total leukocytes and neutrophils counts. Conclusion: These results clearly demonstrate that simvastatin is an effective agent that reduces cytokines levels and leukocyte count in sepsis, independently of its well-known lipid-lowering effects. Thus, HMG-CoA reductase inhibitors like simvastatin have important anti-inflammatory effects in abdominal sepsis in rats

Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures

Amphotericin B (AmB), an antifungal agent that presents a broad spectrum of activity, remains the gold standard in the antifungal therapy. However, sometimes the high level of toxicity forbids its clinical use. The aim of this work was to evaluate and compare the efficacy and toxicity in vitro of Fungizon™ (AmB-D) and two new different AmB formulations. Methods: three products were studied: Fungizon™, and two Fungizon™ /Lipofundin™ admixtures, which were diluted through two methods: in the first one, Fungizon™ was previously diluted with water for injection and then, in Lipofundin™ (AmB-DAL); the second method consisted of a primary dilution of AmB-D as a powder in the referred emulsion (AmB-DL). For the in vitro assay, two cell models were used: Red Blood Cells (RBC) from human donors and Candida tropicallis (Ct). The in vitro evaluation (K+ leakage, hemoglobin leakage and cell survival rate-CSR) was performed at four AmB concentrations (from 50 to 0.05mg.L-1). Results: The results showed that the action of AmB was not only concentration dependent, but also cellular type and vehicle kind dependent. At AmB concentrations of 50 mg.L-1, although the hemoglobin leakage for AmB-D was almost complete (99.51), for AmB-DAL and AmB-DL this value tended to zero. The p = 0.000 showed that AmB-D was significantly more hemolytic. Conclusion: The Fungizon™- Lipofundin™ admixtures seem to be the more valuable AmB carrier systems due to their best therapeutic index presented

Effects of simvastatin in abdominal sepsis in rats

Statins are widely recognized as hypolipemic drugs, but some studies have observed anti-inflammatory and immunomodulatory effects, known as pleiotropic. The aims of this work was to study possible anti-inflammatory effects of simvastatin in abdominal sepsis. Serum pro-inflammatory cytokines and leukocytes count were determined in an experimental model of abdominal sepsis, using cecal ligation and puncture (CLP) in rats. Methods: Twenty eigth Wistar rats weighing 285±12g were randomly divided in: CLP/Sinvastatin rats (n=7), treated with 10 mg/Kg of oral simvastatin 18 and 2 hs berofe CLP; CLP/Saline group rats (n=7), treated with oral saline; group Sham/Simvastatin (n=7), treated with simvastatin, and group Sham/Saline (n=7), treated with saline. Serum TNF-α, IL-1β and IL-6 by ELISA and total leukocytes, neutrophils, lymphocytes, and eosinophils were determined 24 hs after CLP. ANOVA and Tukey test were used considering significant p<0.05. Results: It was demonstrated that serum TNF-α, IL-1β and IL-6 were respectively 364,8±42pg/mL; 46,3±18pg/mL and 28,4±13pg/mL in CLP/Sinvastatin rats, significantly lower (p<0.05) than in group CLP/Saline (778,5±86pg/ml; 176,9±46pg/ ml; 133,6±21 pg/ml, respectively). The same results were observed in total leukocytes and neutrophils counts. Conclusion: These results clearly demonstrate that simvastatin is an effective agent that reduces cytokines levels and leukocyte count in sepsis, independently of its well-known lipid-lowering effects. Thus, HMG-CoA reductase inhibitors like simvastatin have important anti-inflammatory effects in abdominal sepsis in rats

Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures

Amphotericin B (AmB), an antifungal agent that presents a broad spectrum of activity, remains the gold standard in the antifungal therapy. However, sometimes the high level of toxicity forbids its clinical use. The aim of this work was to evaluate and compare the efficacy and toxicity in vitro of Fungizon™ (AmB-D) and two new different AmB formulations. Methods: three products were studied: Fungizon™, and two Fungizon™ /Lipofundin™ admixtures, which were diluted through two methods: in the first one, Fungizon™ was previously diluted with water for injection and then, in Lipofundin™ (AmB-DAL); the second method consisted of a primary dilution of AmB-D as a powder in the referred emulsion (AmB-DL). For the in vitro assay, two cell models were used: Red Blood Cells (RBC) from human donors and Candida tropicallis (Ct). The in vitro evaluation (K+ leakage, hemoglobin leakage and cell survival rate-CSR) was performed at four AmB concentrations (from 50 to 0.05mg.L-1). Results: The results showed that the action of AmB was not only concentration dependent, but also cellular type and vehicle kind dependent. At AmB concentrations of 50 mg.L-1, although the hemoglobin leakage for AmB-D was almost complete (99.51), for AmB-DAL and AmB-DL this value tended to zero. The p = 0.000 showed that AmB-D was significantly more hemolytic. Conclusion: The Fungizon™- Lipofundin™ admixtures seem to be the more valuable AmB carrier systems due to their best therapeutic index presented

Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury.

Electrical neuromodulation of lumbar segments improves motor control after spinal cord injury in animal models and humans. However, the physiological principles underlying the effect of this intervention remain poorly understood, which has limited the therapeutic approach to continuous stimulation applied to restricted spinal cord locations. Here we developed stimulation protocols that reproduce the natural dynamics of motoneuron activation during locomotion. For this, we computed the spatiotemporal activation pattern of muscle synergies during locomotion in healthy rats. Computer simulations identified optimal electrode locations to target each synergy through the recruitment of proprioceptive feedback circuits. This framework steered the design of spatially selective spinal implants and real-time control software that modulate extensor and flexor synergies with precise temporal resolution. Spatiotemporal neuromodulation therapies improved gait quality, weight-bearing capacity, endurance and skilled locomotion in several rodent models of spinal cord injury. These new concepts are directly translatable to strategies to improve motor control in humans.